Cardiovascular adverse events in immune checkpoint inhibitor clinical trials: A U.S. Food and Drug Administration pooled analysis - Amiri-Kordestani, L; Moslehi, J; Cheng, J (J Clinic Oncol, 2018)
(15 Suppl):